111 Capital and a number of other investment firms, including
Ameritas,
Synergy Asset Management, and
Sterling Investment Counsel, among others, have sold their stakes in
Procter & Gamble. On the other hand, groups such as
Ascent Group,
Greenwood Capital Associates, and
Presper Financial Architects, have increased their holdings in the company.
Wells Fargo slashed its price target on the company from $173 to $170, while
Barclays maintained its equal-weight rating. The shaving-brands company also plans to delist Gillette in Pakistan as part of its restructuring plans, which include job reductions and portfolio streamlining, with an intent to boost growth. Analysts generally see the firm as a moderate buy, commending its decades-long increase in dividends making it a cornerstone in recession-proof portfolios. Nevertheless, a bleak outlook was shared by Jim Cramer, arguing that the stock is still way too high. A large Mason expansion project was recently priced by P&G and they predicted that tariffs will start to weigh on its earnings.
Procter Gamble Company PG News Analytics from Thu, 01 May 2025 07:00:00 GMT to Sat, 04 Oct 2025 10:28:48 GMT -
Rating 0
- Innovation 5
- Information 6
- Rumor 4
